200 related articles for article (PubMed ID: 31793219)
1. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
Sharma A; Gupta A; Rawat A; Suri D; Singh S
Int J Rheum Dis; 2020 Mar; 23(3):392-396. PubMed ID: 31793219
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome in patients with juvenile dermatomyositis: A case series.
Chevalier G; Fakih O; Lhose A; Ballot-Schmit C; Prati C; Puzenat E; Aubin F
Arch Pediatr; 2021 Aug; 28(6):475-479. PubMed ID: 34034928
[TBL] [Abstract][Full Text] [Related]
3. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
Sanner H; Sjaastad I; Flatø B
Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.
Mathiesen P; Hegaard H; Herlin T; Zak M; Pedersen FK; Nielsen S
Scand J Rheumatol; 2012 Feb; 41(1):50-8. PubMed ID: 22044089
[TBL] [Abstract][Full Text] [Related]
5. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
[TBL] [Abstract][Full Text] [Related]
6. Juvenile dermatomyositis: a tertiary center experience.
Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
[TBL] [Abstract][Full Text] [Related]
7. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
Al-Mayouf SM; AlMutiari N; Muzaffer M; Shehata R; Al-Wahadneh A; Abdwani R; Al-Abrawi S; Abu-Shukair M; El-Habahbeh Z; Alsonbul A
Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
[TBL] [Abstract][Full Text] [Related]
9. The family impact of caring for a child with juvenile dermatomyositis.
Kountz-Edwards S; Aoki C; Gannon C; Gomez R; Cordova M; Packman W
Chronic Illn; 2017 Dec; 13(4):262-274. PubMed ID: 28133992
[TBL] [Abstract][Full Text] [Related]
10. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.
Rider LG; Lachenbruch PA; Monroe JB; Ravelli A; Cabalar I; Feldman BM; Villalba ML; Myones BL; Pachman LM; Rennebohm RM; Reed AM; Miller FW;
Arthritis Rheum; 2009 Nov; 60(11):3425-35. PubMed ID: 19877055
[TBL] [Abstract][Full Text] [Related]
11. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome.
Saini I; Kalaivani M; Kabra SK
Rheumatol Int; 2016 Jul; 36(7):961-5. PubMed ID: 27007612
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in Juvenile Myositis patients.
Tsaltskan V; Aldous A; Serafi S; Yakovleva A; Sami H; Mamyrova G; Targoff IN; Schiffenbauer A; Miller FW; Simmens SJ; Curiel R; Jones OY; Rider LG
Semin Arthritis Rheum; 2020 Feb; 50(1):149-155. PubMed ID: 31303436
[TBL] [Abstract][Full Text] [Related]
14. Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.
van Dijkhuizen EHP; De Iorio M; Wedderburn LR; Deakin CT;
Arthritis Res Ther; 2018 Aug; 20(1):180. PubMed ID: 30111380
[TBL] [Abstract][Full Text] [Related]
15. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
Sanner H; Gran JT; Sjaastad I; Flatø B
Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
[TBL] [Abstract][Full Text] [Related]
16. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Course of Patients with Juvenile Dermatomyositis - Case Series.
Rajarathinam I; Raghuram J; Rao AP
Neurol India; 2022; 70(1):300-303. PubMed ID: 35263900
[TBL] [Abstract][Full Text] [Related]
18. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
Rider LG; Werth VP; Huber AM; Alexanderson H; Rao AP; Ruperto N; Herbelin L; Barohn R; Isenberg D; Miller FW
Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S118-57. PubMed ID: 22588740
[No Abstract] [Full Text] [Related]
19. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.
Ravelli A; Trail L; Ferrari C; Ruperto N; Pistorio A; Pilkington C; Maillard S; Oliveira SK; Sztajnbok F; Cuttica R; Beltramelli M; Corona F; Katsicas MM; Russo R; Ferriani V; Burgos-Vargas R; Magni-Manzoni S; Solis-Valleoj E; Bandeira M; Zulian F; Baca V; Cortis E; Falcini F; Alessio M; Alpigiani MG; Gerloni V; Saad-Magalhaes C; Podda R; Silva CA; Lepore L; Felici E; Rossi F; Sala E; Martini A
Arthritis Care Res (Hoboken); 2010 Jan; 62(1):63-72. PubMed ID: 20191492
[TBL] [Abstract][Full Text] [Related]
20. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
